Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial

Rogers, Benjamin (Primary Chief Investigator (PCI))
Shehabi, Yahya (Chief Investigator (CI))
Stuart, Rhonda (Chief Investigator (CI))
Harris, Patrick (Chief Investigator (CI))
Daneman, Nick (Chief Investigator (CI))
Fowler, Robert A. (Chief Investigator (CI))
Bulfin, Lauren (Chief Investigator (CI))

Project: Research

Short title	The Balance Study
Acronym	BALANCE
Status	Finished
Effective start/end date	1/01/19 → 31/12/24

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$1,233,368.60

1 Article

Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial
Rogers, B. A., Fowler, R., Harris, P. N. A., Davis, J. S., Pinto, R. L., Bhatia Dwivedi, D., Rishu, A., Shehabi, Y. & Daneman, N., 26 Jun 2023, In: BMJ Open. 13, 6, 16 p., e069708.
Research output: Contribution to journal › Article › Other › peer-review

Open Access

2 Citations (Scopus)